Skip to content
Trial Eligibility
Menu

Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

NCT07090005

This study is recruiting at 4 US sites in 3 states, according to its ClinicalTrials.gov record last updated .

Summary

evaluation of the EndoZip system procedure compared to the Apollo ESG procedure in obese patients.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Obesity
  • Overweight

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
21 to 65 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Nitinotes Surgical Ltd.
Last updated on ClinicalTrials.gov
October 1, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • Cedars Sinai Medical Center · Los Angeles, CA

Florida · 1

  • Orlando Health, Inc. · Orlando, FL

New York · 2

  • Lenox Hill Hospital | Northwell Health · New York, NY
  • Weill Cornell -1300 York Avenue · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.